Changes of antithrombin III and antithrombin III-heparin complex levels, and ACT in cardiac surgery.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Pathological and inconspicuous AT III measuring values were compared with the clinical findings (arterial occlusive diseases, postthrombotic syndromes, acute profound thrombosis of the pelvic veins and the leg veins, acute heparin tolerance in several basic diseases). After calculatory elaboration of all rightly positive and falsely positive, rightly negative and falsely negative laboratory results becomes evident that the positive power of prognosis of the AT III determination is unsatisfactory for a certain basic disease and the negative evidence in these questionings rather well satisfy for the functional measuring method. - The sensitivity of the functional AT III test for the recognition of increased heparin tolerances is quite satisfactory, and the test for the answer of this questioning also suitable and more sensitive than the immunological proof method. - The high percentage of rightly positive and rightly negative findings of all tested results of apparently healthy persons and the groups of patients represented makes clear, which role plays the AT III as a physiologic inhibitor against coagulation-active serine proteases particularly in DIC and in profound thrombosis of the pelvic and leg veins. - For the observation of the course in profound thrombosis of the pelvic and led veins, features of postthrombotic condition and the DIC at least the functional determination of AT III is decisively important.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Affinity chromatography of plasma and serum with the use of heparin conjugated Sepharose has confirmed the existence of two types of protein binding sites. A minor heparin fraction binds free AT III selectively and firmly but not its protease complexes. The complexes bind less firmly to another, much larger heparin fraction together with a select group of the plasma proteins at physiological pH and ionic strength. These included complement proteins (C1q, C2, factor B, properdin, and beta 1H), protease inhibitors (inter-alpha-trypsin inhibitor and C3b inactivator) and cell surface proteins (protein HC and fibronectin) as well as beta-lipoproteins. The results demonstrate that affinity chromatography with heparin-Sepharose is extremely useful as an early preparative step in the isolation of these minor plasma components. The results also indicate that the said proteins can be linked to cell surfaces carrying heparinoids in the intercellular space.
Explore the source record for details and available documents.